Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
oleh: Seyed Nabavi, Solomon Habtemariam, Emilio Clementi, Ioana Berindan-Neagoe, Cosmin Cismaru, Mahsa Rasekhian, Maciej Banach, Morteza Izadi, Mahdi Bagheri, Mohammad Bagheri, Seyed Nabavi
| Format: | Article |
|---|---|
| Diterbitkan: | Termedia Publishing House 2020-04-01 |
Deskripsi
No description available for this item.